翰宇药业：曾少贵累计质押股数约为6449万股

Group 1 - The core point of the article highlights the significant share pledges by major shareholders of Hanyu Pharmaceutical, indicating potential liquidity concerns [1] - As of the announcement date, the cumulative pledged shares by Zeng Shaogui amount to approximately 64.49 million shares, representing 65.45% of his holdings [1] - Zeng Shaoqiang has pledged approximately 37.66 million shares, which is 59.64% of his holdings, while Zeng Shaobin has pledged 8.5 million shares, accounting for 39.14% of his holdings [1] Group 2 - For the first half of 2025, Hanyu Pharmaceutical's revenue composition is entirely from the pharmaceutical manufacturing sector, with a 100% contribution [1] - The current market capitalization of Hanyu Pharmaceutical is 18.5 billion yuan [1]